Browsing by Author "Ulger, B. V."
Now showing items 1-4 of 4
-
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors
Yilmaz, V. T.; Aliosmanoglu, I.; Erbis, H.; Ulger, B. V.; Cetinkaya, R.; Suleymanlar, G.; Kocak, H. (Wiley, 2016)AimThe aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients. Patients and methodA ... -
Factors affecting morbidity and mortality in pancreatic injuries
Bozdag, Z.; Kapan, M.; Ulger, B. V.; Turkoglu, A.; Uslukaya, O.; Oguz, A.; Aldemir, M. (Springer Heidelberg, 2016)Difficulties in the detection of pancreatic damage result in morbidity and mortality in cases of pancreatic trauma. This study was performed to determine factors affecting morbidity and mortality in pancreatic trauma. The ... -
The Protective Effect of Ellagic Acid on Lung Damage Caused by Experimental Obstructive Jaundice Model
Gul, M.; Aliosmanoglu, I.; Uslukaya, O.; Firat, U.; Yuksel, H.; Gumus, M.; Ulger, B. V. (Acta Medical Belgica, 2013)Aim : This study aimed to investigate protective effects of ellagic acid on lungs in an experimental obstructive jaundice model. Methods : Four groups were established, each consisting of ten randomly selected rats : Group ... -
A Successful Renal Transplantation Case After Stem Cell Transplantation
Yilmaz, V. T.; Koksoy, S.; Ulger, B. V.; Salim, O.; Akbas, H.; Aliosmanoglu, I.; Erbis, H. (Elsevier Science Inc, 2015)Renal transplantation is the most effective treatment method for end-stage renal disease (ESRD). However, new treatment modalities are being investigated, such as immunotoleration, to avoid the acute and chronic side effects ...
